(Q50567928)
Statements
Immunogenicity of interferon-beta in multiple sclerosis patients: influence of preparation, dosage, dose frequency, and route of administration. Danish Multiple Sclerosis Study Group. (English)
1 reference
Ross C
1 reference
Clemmesen KM
1 reference
Svenson M
1 reference
Sørensen PS
1 reference
Koch-Henriksen N
1 reference
Skovgaard GL
1 reference
Bendtzen K
1 reference
1 November 2000
1 reference
48
1 reference
5
1 reference
706-712
1 reference